You are here: Industry Insights > Firdapse

News List

Catalyst Announces Issuance of U.S. Patent for Firdapse americanpharmaceuticalreview
October 10, 2020
Catalyst Pharmaceuticals announced the United States Patent and Trademark Office (USPTO) has issued a new U.S. patent to Catalyst Pharmaceuticals for Firdapse® (amifampridine), U.S. Patent No. 10,793,893, Methods of Administering 3,4-Diaminopyridine ...
Sanders escalates fight with Catalyst, asking FDA to allow unbranded copies of $375K Firdapse fiercepharma
March 03, 2019
After a seemingly vain attempt to appeal to Catalyst Pharmaceuticals’ conscience, Sen. Bernie Sanders, I-Vt., has turned to the FDA, asking the agency to allow cheaper, unapproved versions of Catalyst’ Firdapse to be distributed as they had been over the
Catalyst holds firm on $300,000-plus net for Firdapse despite Bernie Sanders’ demands to justify the price fiercepharma
February 24, 2019
Just one week after Vermont Sen. Bernie Sanders sent a scathing letter to Catalyst Pharmaceuticals CEO questioning his plans to charge $375,000 for its rare-disease drug Firdapse, the company said it's sticking to that number.
Catalyst holds firm on $300,000-plus net for Firdapse despite Bernie Sanders’ demands to justify the price fiercepharma
February 24, 2019
Just one week after Vermont Sen. Bernie Sanders sent a scathing letter to Catalyst Pharmaceuticals CEO questioning his plans to charge $375,000 for its rare-disease drug Firdapse, the company said it's sticking to that number.
Firdapse (Amifampridine) Approved for Rare Autoimmune Disorder drugs
November 30, 2018
Firdapse (amifampridine) tablets have been approved by the U.S. Food and Drug Administration for adults with Lambert-Eaton myasthenic syndrome (LEMS).....
FDA Approves Firdapse for Rare Autoimmune Disorder drugs
November 30, 2018
Firdapse (amifampridine) tablets have been approved by the U.S. Food and Drug Administration for adults with Lambert-Eaton myasthenic syndrome (LEMS)......
FDA Approves First Treatment for Lambert-Eaton Myasthenic Syndrome americanpharmaceuticalreview
November 30, 2018
The U.S. Food and Drug Administration (FDA) approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults....